Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer

被引:173
作者
Arru, Marcella [1 ]
Aldrighetti, Luca [1 ]
Castoldi, Renato [1 ]
Di Palo, Saverio [1 ]
Orsenigo, Elena [1 ]
Stella, Marco [1 ]
Pulitano, Carlo [1 ]
Gavazzi, Francesca [1 ]
Ferla, Gianfranco [1 ]
Di Carlo, Valerio [1 ]
Staudacher, Carlo [1 ]
机构
[1] Ist Sci San Raffaele, Dept Surg, Liver Unit, I-20132 Milan, Italy
关键词
D O I
10.1007/s00268-007-9285-y
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background The aim of this study was to analyze the prognostic factors associated with long-term outcome after liver resection for colorectal metastases. The retrospective analysis included 297 liver resections for colorectal metastases. Methods The variables considered included disease stage, differentiation grade, site and nodal metastasis of the primary tumor, number and diameter of the lesions, time from primary cancer to metastasis, preoperative carcinoembryonic antigen (CEA) level, adjuvant chemotherapy, type of resection, intraoperative ultrasonography and portal clamping use, blood loss, transfusions, complications, hospitalization, surgical margins status, and a clinical risk score (MSKCC-CRS). Results The univariate analysis revealed a significant difference (p < 0.05) in overall 5-year survival rates depending on the differentiation grade, preoperative CEA > 5 and > 200 ng/ml, diameter of the lesion > 5 cm, time from primary tumor to metastases > 12 months, MSKCC-CRS > 2. The multivariate analysis showed three independent negative prognostic factors: G3 or G4 grade, CEA > 5 ng/ml, and high MSKCC-CRS. Conclusions No single prognostic factor proved to be associated with a sufficiently disappointing outcome to exclude patients from liver resection. However, in the presence of some prognostic factors (G3-G4 differentiation, preoperative CEA > 5 ng/ml, high MSKCC-CRS), enrollment of patients in trials exploring new adjuvant treatments is suggested to improve the outcome after surgery.
引用
收藏
页码:93 / 103
页数:11
相关论文
共 47 条
[1]  
Abdalla EK, 2004, ANN SURG, V239, P818, DOI 10.1097/01.sla.0000128305.90650.71
[2]   Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors [J].
Adam, R ;
Laurent, A ;
Azoulay, D ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2000, 232 (06) :777-784
[3]   Liver resection for colorectal metastases - The third hepatectomy [J].
Adam, R ;
Pascal, G ;
Azoulay, D ;
Tanaka, K ;
Castaing, D ;
Bismuth, H .
ANNALS OF SURGERY, 2003, 238 (06) :871-883
[4]  
Adam Rene, 2003, Surg Oncol Clin N Am, V12, P211, DOI 10.1016/S1055-3207(02)00085-6
[5]  
[Anonymous], HPB
[6]   Determinants of survival following hepatic resection for metastatic colorectal cancer [J].
Bakalakos, EA ;
Kim, JA ;
Young, DC ;
Martin, EW .
WORLD JOURNAL OF SURGERY, 1998, 22 (04) :399-405
[7]  
BENGMARK S, 1969, CANCER, V23, P198, DOI 10.1002/1097-0142(196901)23:1<198::AID-CNCR2820230126>3.0.CO
[8]  
2-J
[9]   Size of surgical margin does not influence recurrence rates after curative liver resection for colorectal cancer liver metastases [J].
Bodingbauer, M. ;
Tamandl, D. ;
Schmid, K. ;
Plank, C. ;
Schimai, W. ;
Gruenberger, T. .
BRITISH JOURNAL OF SURGERY, 2007, 94 (09) :1133-1138
[10]   Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma [J].
Bolton, JS ;
Fuhrman, GM .
ANNALS OF SURGERY, 2000, 231 (05) :743-750